In this Issue:
Effects of RBC storage duration in cardiac surgery
Age of transfused RBCs in critically ill adults
Restrictive vs. liberal RBC transfusion strategy
Ruxolitinib for myelofibrosis
Pacritinib for myelofibrosis
3-year follow-up of ibrutinib in CLL and SLL
CLL outcomes after ibrutinib discontinuation
Watch and wait for advanced-stage FL
Predicting survival and toxicity in elderly MM
Please login below to download this issue (PDF)